A Comparison of Peri-Procedural Myocardial Infarction between Paclitaxel-Coated Balloon and Drug-Eluting Stent on De Novo Coronary Lesions.
- Author:
Ae Young HER
1
;
Kyoung Im CHO
;
Gillian Balbir SINGH
;
Scot GARG
;
Yong Hoon KIM
;
Bon Kwon KOO
;
Eun Seok SHIN
Author Information
- Publication Type:Comparative Study ; Observational Study ; Original Article
- Keywords: Paclitaxel-coated balloon; drug eluting stent; peri-procedural; myocardial infarction; de novo coronary artery
- MeSH: Aged; Creatine Kinase, MB Form/analysis; *Drug-Eluting Stents; Female; Humans; Incidence; Kaplan-Meier Estimate; Middle Aged; Myocardial Infarction/enzymology/epidemiology/etiology/*prevention & control; Odds Ratio; Paclitaxel/*therapeutic use; Percutaneous Coronary Intervention/*adverse effects; Propensity Score; Time Factors; Treatment Outcome
- From:Yonsei Medical Journal 2017;58(1):99-104
- CountryRepublic of Korea
- Language:English
- Abstract: PURPOSE: This study compared the impact of paclitaxel-coated balloons (PCB) or drug eluting stents (DES) on peri-procedural myocardial infarction (PMI) on de novo coronary lesion in stable patients. MATERIALS AND METHODS: In this observational study, we compared the incidence of PMI amongst patients with single vessel de novo coronary lesions who underwent treatment with a PCB or DES. Propensity score-matching analysis was used to assemble a cohort of patients with similar baseline characteristics. PMI was classified as myocardial infarction occurring within 48 hours after percutaneous coronary intervention with a threshold of 5 x the 99th percentile upper reference limit of normal for creatine kinase-myocardial band (CK-MB) or troponin T (TnT). RESULTS: One hundred four patients (52 receiving PCB and 52 receiving DES) were enrolled in this study. The peak mean values of CK-MB and TnT were significantly higher in the DES group. There was a significantly higher rate of PMI in the DES group (23.1% vs. 1.9%, p=0.002). Total occlusion of the side-branch occurred in two patients treated with DES, while no patients treated with PCB. In multivariable analysis, DES was the only independent predictor of PMI compared with PCB (odds ratio 42.85, 95% confidence interval: 3.44–533.87, p=0.004). CONCLUSION: Treatment with a PCB on de novo coronary lesion might be associated with a significant reduction in the risk of PMI compared to DES.
